Race takes place on Sunday, May 29
Runners find inspiration, preparing for Bayer Newbury 10k
With the race and its associated junior events noted for inspiring hundreds to raise money for charity, the motivation for runners ranges from charitable to personal, with many running the event for the first time.
“I have watched the race go past my front door for the past few years and the runners always appear to be having fun,” said one participant, who has decided to lace up his trainers and have a go himself, rather than miss out on the fun. Others say they want to improve their health and raise money for charities which give people a better quality of life.
“I have lost over five stones in weight from exercising,” said one runner.
“I felt inspired by my best friends who are raising money for Diabetes UK by participating in lots of events. In turn, I am their inspiration as I have type 1 diabetes.”
“I started the ‘Couch to 5k plan in October having done no sort of exercise before and wanted to do it to lose weight. This will be a massive achievement for me, and I will be raising money for NSPCC”
Bayer race co-ordinator, Wendy Elsey, said: “These are just a few of the reasons our runners have given us for wanting to take part. What’s become clear over the years is that the Bayer Newbury 10k has helped many people to step out of their comfort zone and do something they’ve never done before, and in doing so they are having a lot of fun as well as helping themselves towards a healthier life. As a life sciences company with a strong focus on healthcare, it’s something we wholeheartedly applaud.”
With entries now coming in steadily, and just six weeks left to the big day, race directors Newbury AC are reminding runners to go to www.bayer.co.uk to find a link to details about the race and the entry form.
Becky Coxhead, Newbury AC, said: “We’d like to remind people to get their entries in sooner than later. We have categories for every runner, including a team event, and of course there are two shorter junior races on the day, for 5-11-year-olds and for under 16s. It is a real family day out, so please join in the fun! There is great support from all our volunteers, a fantastic atmosphere, medals and a goody bag for all finishers to remember their day.”
The Bayer Newbury 10k is now in its ninth year. The event will support Naomi House and Jacksplace, hospices for children and young people with life-limiting conditions. Proceeds from entry fees, which last year topped £13,000, will be split between the hospices and Newbury AC. Other charities also receive a big boost from the Bayer Newbury 10k, with many runners raising cash for causes close to their hearts.
Starting in Newbury Market Place, the 10k race follows roads and pathways around Newbury. Juniors race on a traffic free town centre route. There are cash prizes and trophies for category winners, as well as runners up prizes in the male and female overall categories.
Notes to editors:
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2014, the Group employed around 119,000 people and had sales of EUR 42.2 billion. Capital expenditures amounted to EUR 2.5 billion, R&D expenses to EUR 3.6 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.
Bayer’s offices in the UK and Ireland are located in Newbury (head office), Cambridge and Dublin. For more information, go to www.bayer.co.uk
Follow us on Twitter at: www.twitter.com/BayerUkIreland
Follow us on YouTube at: www.youtube.com/BayerUKIre
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conformthem to future events or developments.